# Bioequivalence Study of GZR4 Injection With Different Manufacturing Processes in Healthy Adult Participants

> **NCT07670897** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Gan & Lee Pharmaceuticals.** · enrollment: 64 (estimated)

## Conditions studied

- T2D

## Interventions

- **DRUG:** GZR4 injection A
- **DRUG:** GZR4 injection B

## Key facts

- **NCT ID:** NCT07670897
- **Lead sponsor:** Gan & Lee Pharmaceuticals.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2026-07-29
- **Final completion:** 2026-07-29
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2026-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07670897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07670897, "Bioequivalence Study of GZR4 Injection With Different Manufacturing Processes in Healthy Adult Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07670897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*